Table 1.
Demographic and clinical characteristics of the study groups after propensity score matching.
| −DDP4i | +DDP4i | p Value | |
|---|---|---|---|
| Number of Patients | 16 | 16 | |
| Gender F/M | 5/11 | 6/10 | ns |
| Age (yrs) | 69.8 ± 2.2 | 72.38 ± 2.98 | ns |
| Body Mass Index (BMI) | 28.12 ± 1.33 | 25.6 ± 1.26 | ns |
| Duration of Diabetes (yrs) | 7.87 ± 1.81 | 20.94 ± 3.18 | 0.0015 |
| HbA1c (mmol/mol) | 52 (43.75–63.25) | 49 (45.25–54) | ns |
| Total Cholesterol (mg/dL) | 166.2 ± 10.14 | 152.2 ± 8.07 | ns |
| High Density Lipoprotein (HDL) (mg/dL) | 47.5 (37.5–56) | 49.5 (41.75–56) | ns |
| Triglycerides (mg/dL) | 144.9 ± 13.48 | 122.1 ± 11.14 | ns |
| Estimated glomerular filtration rate (eGRF) (mL/min) | 79 (68.5–90) | 54.5 (27.25–89.75) | 0.0027 |
| Micro Complications (yes/no) | 4/12 | 10/6 | ns |
| Macro Complications (yes/no) | 4/12 | 5/11 | ns |
Data are expressed as means ± standard deviation (SD). Non-normally distributed variables are expressed as median and interquartile range.